Related Experiment Video
Updated: Apr 14, 2026

Visualizing Leukocyte Rolling and Adhesion in Angiotensin II-Infused Mice: Techniques and Pitfalls
Published on: January 4, 2018
Inflammation and Arterial Hypertension: From Pathophysiological Links to Risk Prediction
Panagiota Pietri, Charalambos Vlachopoulos1, Dimitris Tousoulis
1Hypertension Unit, 1st Cardiology Department, Athens Medical School, Hippokration Hospital, Profiti Elia 24, 14575 Athens, Greece. cvlachop@otenet.gr.
Insights
Low-grade inflammation plays a key role in atherosclerosis and cardiovascular disease. This review discusses the bidirectional link between arterial hypertension and inflammation, highlighting clinical implications.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Pathophysiology
Background:
- Low-grade inflammation is central to atherosclerosis and cardiovascular disease (CVD).
- Inflammatory activation increases cardiovascular events, acting as a substrate or trigger.
- Arterial hypertension and inflammation share a bidirectional relationship, each exacerbating the other.
Purpose of the Study:
- To review the association between arterial hypertension and low-grade inflammation.
- To discuss the underlying pathophysiological pathways.
- To explore the clinical implications of this relationship.
Main Methods:
- Literature review of studies investigating the link between hypertension and inflammation.
- Analysis of data on inflammatory biomarkers in hypertensive patients.
- Discussion of proposed mechanisms connecting hypertension and inflammation.
Main Results:
- Inflammatory biomarkers like high-sensitivity C-reactive protein predict hypertension incidence and outcomes.
- Arterial hypertension can enhance inflammatory processes.
- Inflammation can contribute to the development and progression of hypertension.
Conclusions:
- The interplay between arterial hypertension and low-grade inflammation is significant in cardiovascular health.
- Understanding these pathways is crucial for managing hypertensive patients and preventing cardiovascular events.
- Targeting inflammation may offer novel therapeutic strategies for hypertension and related CVD.
Abstract:
Over the last years, ample data have demonstrated the pivotal role of low-grade inflammation in the pathophysiology of atherosclerosis and cardiovascular disease. It is well established that inflammatory activation, serving either as a substrate, in the chronic phase of atherosclerotic disease, or as a trigger, in the acute phase, increases cardiovascular events. Considering hypertension, the inflammatory process is implicated in its pathophysiology through a bidirectional relationship since arterial hypertension may enhance inflammation and vice versa. Inflammatory biomarkers such as high-sensitivity C-reactive protein, have shown predictive value for both the incidence of hypertension and the clinical outcomes in hypertensive patients. In the present review, data on the association between arterial hypertension and low-grade inflammation will be reported and potential pathophysiological pathways and clinical implications underlying this association will be discussed.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies

